[Form 4] Cal-Maine Foods Inc Insider Trading Activity
Melanie Boulden, a Director of Cal-Maine Foods, Inc. (CALM), was granted 938 shares of time-vesting restricted common stock on 08/11/2025. The award was recorded at a $0 price and increases her direct beneficial ownership to 938 shares. The restricted shares are scheduled to vest on January 14, 2028. The Form 4 was submitted on 08/14/2025 and signed on her behalf under power of attorney. The filing documents a routine director equity grant that becomes unrestricted only after the stated vesting date.
Melanie Boulden, direttore di Cal-Maine Foods, Inc. (CALM), ha ricevuto 938 azioni ordinarie vincolate con scadenza temporale il 11/08/2025. L鈥檃ssegnazione 猫 stata registrata a valore 0 e porta la sua partecipazione diretta a 938 azioni. Le azioni vincolate matureranno il 14 gennaio 2028. Il Modello 4 猫 stato presentato il 14/08/2025 e firmato per suo conto tramite procura. La documentazione descrive una concessione di azioni routine per un direttore che diventa libera da vincoli solo dopo la data di maturazione indicata.
Melanie Boulden, directora de Cal-Maine Foods, Inc. (CALM), recibi贸 938 acciones ordinarias restringidas con vencimiento temporal el 11/08/2025. La adjudicaci贸n se registr贸 a precio 0 y eleva su propiedad directa a 938 acciones. Las acciones restringidas vencer谩n el 14 de enero de 2028. El Formulario 4 se present贸 el 14/08/2025 y fue firmado en su nombre mediante poder. El expediente documenta una concesi贸n de acciones habitual para un director que solo quedar谩 libre de restricciones tras la fecha de vencimiento indicada.
氅滊澕雼� 氤茧摖(Melanie Boulden) 旃�-氅旍澑 響胳(Cal-Maine Foods, Inc., CALM) 鞚挫偓電� 2025-08-11鞐� 鞁滉皠 旮半皹 鞝滍暅 氤错喌欤� 938欤茧ゼ 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 靾橃儊鞚� $0搿� 旮半霅橃棃鞙茧┌ 攴鸽厐鞚� 歆侅爲 氤挫湢 歆�攵勳潃 938欤茧 歃濌皜頄堨姷雼堧嫟. 鞝滍暅欤检嫕鞚� 2028雲� 1鞗� 14鞚检棎 頇曥爼(氩犾姢韺�)霅� 鞓堨爼鞛呺媹雼�. Form 4電� 2025-08-14鞐� 鞝滌稖霅橃棃瓿� 鞙勳瀯鞛�(韺岇泴 鞓る笇 鞏错啝雼�)鞙茧 攴鸽厐毳� 雽�鞁犿暣 靹滊獏霅橃棃鞀惦媹雼�. 頃措嫻 靹滊電� 氇呾嫓霅� 頇曥爼鞚� 鞚错泟鞐愲 鞝滍暅鞚� 頃挫牅霅橂姅 鞚挫偓鞚� 韱奠儊鞝� 欤检嫕 攵�鞐ゼ 氍胳劀頇旐暕雼堧嫟.
Melanie Boulden, administratrice de Cal-Maine Foods, Inc. (CALM), s鈥檈st vu attribuer 938 actions ordinaires restreintes 脿 acquisition progressive le 11/08/2025. L鈥檃ttribution a 茅t茅 enregistr茅e 脿 un prix de 0 $ et porte sa participation directe 脿 938 actions. Les actions restreintes seront acquises le 14 janvier 2028. Le Formulaire 4 a 茅t茅 d茅pos茅 le 14/08/2025 et sign茅 en son nom par procuration. Le dossier documente une attribution d鈥檃ctions de directeur routini猫re qui ne devient libre de toute restriction qu鈥檃pr猫s la date d鈥檃cquisition indiqu茅e.
Melanie Boulden, Direktorin von Cal-Maine Foods, Inc. (CALM), wurden am 11.08.2025 938 zeitgebundene eingeschr盲nkte Stammaktien gew盲hrt. Die Zuteilung wurde mit einem Preis von 0 $ verbucht und erh枚ht ihren direkten Eigentumsanteil auf 938 Aktien. Die eingeschr盲nkten Aktien sollen am 14. Januar 2028 vesten. Das Formblatt 4 wurde am 14.08.2025 eingereicht und in ihrem Namen per Vollmacht unterschrieben. Die Einreichung dokumentiert eine routinem盲脽ige Aktienzuteilung f眉r eine Direktorin, die erst nach dem angegebenen Vesting-Datum frei von Beschr盲nkungen ist.
- Director-share alignment: The restricted stock grant ties the directors interests to long-term company performance through vesting.
- Clear disclosure: The Form 4 documents the transaction date, share amount, vesting date, and beneficial ownership, meeting reporting requirements.
- None.
Insights
TL;DR: Small director equity grant; limited near-term market impact but aligns incentives with shareholders until vesting.
This 938-share restricted stock grant represents a modest compensation event for a board member. At a reported price of $0 the instrument is compensatory rather than a market purchase and will not immediately affect public float or cash flow. Materiality is low given the small share count relative to typical public company floats, but the vesting schedule (01/14/2028) ties the directors interest to multi-year performance horizons, which can be viewed positively for long-term alignment.
TL;DR: Standard governance practice: time-vesting equity for a director with customary disclosure; no governance red flags evident.
The disclosure identifies the reporting person as a director and describes a time-vesting restricted stock grant with a clear vesting date. The Form 4 was properly filed and executed via power of attorney, which is common. There are no indications of unusual option repricing, non-standard transfer restrictions, or immediate disposal. From a governance perspective this is routine director compensation disclosure.
Melanie Boulden, direttore di Cal-Maine Foods, Inc. (CALM), ha ricevuto 938 azioni ordinarie vincolate con scadenza temporale il 11/08/2025. L鈥檃ssegnazione 猫 stata registrata a valore 0 e porta la sua partecipazione diretta a 938 azioni. Le azioni vincolate matureranno il 14 gennaio 2028. Il Modello 4 猫 stato presentato il 14/08/2025 e firmato per suo conto tramite procura. La documentazione descrive una concessione di azioni routine per un direttore che diventa libera da vincoli solo dopo la data di maturazione indicata.
Melanie Boulden, directora de Cal-Maine Foods, Inc. (CALM), recibi贸 938 acciones ordinarias restringidas con vencimiento temporal el 11/08/2025. La adjudicaci贸n se registr贸 a precio 0 y eleva su propiedad directa a 938 acciones. Las acciones restringidas vencer谩n el 14 de enero de 2028. El Formulario 4 se present贸 el 14/08/2025 y fue firmado en su nombre mediante poder. El expediente documenta una concesi贸n de acciones habitual para un director que solo quedar谩 libre de restricciones tras la fecha de vencimiento indicada.
氅滊澕雼� 氤茧摖(Melanie Boulden) 旃�-氅旍澑 響胳(Cal-Maine Foods, Inc., CALM) 鞚挫偓電� 2025-08-11鞐� 鞁滉皠 旮半皹 鞝滍暅 氤错喌欤� 938欤茧ゼ 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 靾橃儊鞚� $0搿� 旮半霅橃棃鞙茧┌ 攴鸽厐鞚� 歆侅爲 氤挫湢 歆�攵勳潃 938欤茧 歃濌皜頄堨姷雼堧嫟. 鞝滍暅欤检嫕鞚� 2028雲� 1鞗� 14鞚检棎 頇曥爼(氩犾姢韺�)霅� 鞓堨爼鞛呺媹雼�. Form 4電� 2025-08-14鞐� 鞝滌稖霅橃棃瓿� 鞙勳瀯鞛�(韺岇泴 鞓る笇 鞏错啝雼�)鞙茧 攴鸽厐毳� 雽�鞁犿暣 靹滊獏霅橃棃鞀惦媹雼�. 頃措嫻 靹滊電� 氇呾嫓霅� 頇曥爼鞚� 鞚错泟鞐愲 鞝滍暅鞚� 頃挫牅霅橂姅 鞚挫偓鞚� 韱奠儊鞝� 欤检嫕 攵�鞐ゼ 氍胳劀頇旐暕雼堧嫟.
Melanie Boulden, administratrice de Cal-Maine Foods, Inc. (CALM), s鈥檈st vu attribuer 938 actions ordinaires restreintes 脿 acquisition progressive le 11/08/2025. L鈥檃ttribution a 茅t茅 enregistr茅e 脿 un prix de 0 $ et porte sa participation directe 脿 938 actions. Les actions restreintes seront acquises le 14 janvier 2028. Le Formulaire 4 a 茅t茅 d茅pos茅 le 14/08/2025 et sign茅 en son nom par procuration. Le dossier documente une attribution d鈥檃ctions de directeur routini猫re qui ne devient libre de toute restriction qu鈥檃pr猫s la date d鈥檃cquisition indiqu茅e.
Melanie Boulden, Direktorin von Cal-Maine Foods, Inc. (CALM), wurden am 11.08.2025 938 zeitgebundene eingeschr盲nkte Stammaktien gew盲hrt. Die Zuteilung wurde mit einem Preis von 0 $ verbucht und erh枚ht ihren direkten Eigentumsanteil auf 938 Aktien. Die eingeschr盲nkten Aktien sollen am 14. Januar 2028 vesten. Das Formblatt 4 wurde am 14.08.2025 eingereicht und in ihrem Namen per Vollmacht unterschrieben. Die Einreichung dokumentiert eine routinem盲脽ige Aktienzuteilung f眉r eine Direktorin, die erst nach dem angegebenen Vesting-Datum frei von Beschr盲nkungen ist.
FAQ
What transaction did Melanie Boulden report on Form 4 for CALM?
When do the restricted shares granted to Melanie Boulden vest?
How many shares does Melanie Boulden beneficially own after the transaction?
Was there a purchase price reported for the restricted shares?
When was the Form 4 filed and who signed it?
